Sphera Funds Management’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.21M | Sell |
128,780
-252,300
| -66% | -$2.37M | 0.28% | 72 |
|
|
2025
Q1 | $2.71M | Sell |
381,080
-85,000
| -18% | -$604K | 0.62% | 48 |
|
|
2024
Q4 | $5.43M | Buy |
466,080
+175,000
| +60% | +$2.04M | 0.98% | 36 |
|
|
2024
Q3 | $5.98M | Buy |
291,080
+151,661
| +109% | +$3.12M | 0.95% | 38 |
|
|
2024
Q2 | $3.12M | Buy |
+139,419
| New | +$3.12M | 0.43% | 61 |
|
|
2021
Q4 | – | Sell |
-23,647
| Closed | -$3.17M | – | 109 |
|
|
2021
Q3 | $3.17M | Sell |
23,647
-28,903
| -55% | -$3.88M | 0.27% | 73 |
|
|
2021
Q2 | $8.51M | Buy |
+52,550
| New | +$8.51M | 0.58% | 37 |
|
|
2018
Q2 | – | Sell |
-160,000
| Closed | -$3.37M | – | 115 |
|
|
2018
Q1 | $3.37M | Buy |
+160,000
| New | +$3.37M | 0.51% | 53 |
|